Adrenogenital disorders
- E25 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM E25 became effective on October 1, 2024.
- This is the American ICD-10-CM version of E25 – other international versions of ICD-10 E25 may differ.
Type 1 Excludes
- indeterminate sex and pseudohermaphroditism (Q56)
- chromosomal abnormalities (Q90-Q99 )
Includes
- adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
- Female adrenal pseudohermaphroditism
- Female heterosexual precocious pseudopuberty
- Male isosexual precocious pseudopuberty
- Male macrogenitosomia praecox
- Male sexual precocity with adrenal hyperplasia
- Male virilization (female)
The following code(s) above E25 contain annotation back-references
that may be applicable to E25:
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to E25:
- Type 1 Excludes: Q56, E30.1, E30.1, Q89.1